Implantation of the embryo in the uterus is essential for successful pregnancy. This multistage event consists of the attachment and adherence of the blastocyst to the endometrium, followed by its invasion through the luminal epithelium into the stroma, where it generates the placenta that in turn, nourishes the developing fetus throughout pregnancy. This intricate crosstalk, between the blastocyst and the receptive endometrium is mediated by different cytokines, and opens the gateway for further embryonic development. The endometrium is receptive during a limited period known as the window of implantation (WOI) that extends, in human, between days 19 and 23 of the menstrual cycle. The synchronization between the preparation of the endometrium and early embryonic development is therefore fundamental for successful implantation. It is the regulation of the ovarian sex steroid hormones, estrogen (E 2 ) and progesterone (P 4 ), which allows follicular development, ovulation, and blastocyst formation to synchronize with the development of a receptive endometrium.
Development of a Receptive Endometrium
The preparation of the endometrium is hormone dependent. The pituitary gonadotropins follicle-stimulating hormone and luteinizing hormone stimulate the ovary to secrete the sex steroids E 2 and P 4 . Proliferation of the endometrial cells is induced by E 2 , which is mainly secreted during the first half of the menstrual cycle, referred to as the proliferative phase. The predominant sex steroid in the second half of the cycle, known as the secretory phase, is P 4 , which induces the differentiation of the endometrial cells. This phase of the cycle is characterized by the formation of glands that secrete large amounts of cytokines and growth factors, vascularization, infiltration of the endometrium by a variety of immune cells from the blood, edema of the tissue caused by a localized increase in vascular permeability, and decidualization of the stromal cells.
1 It is important to note that in humans, decidualization (differentiation of the stromal cells) begins spontaneously during the secretory phase, unlike rodents, in which decidualization requires embryo implantation or another local mechanical stimulation.
uterus. Different studies, most of which employed mouse experimental models, showed that of the two E 2 receptors, ERα and ERβ, the ERα is the predominant mediator of the activity of this hormone in the endometrium. Mice that are Erα -/-exhibited hypoplastic uteri that could not support implantation, whereas in Erβ -/-mice, implantation was normal.
2 Specifically, epithelial cell directed deletion of ERα caused a decrease in the synthesis of epithelial lactoferrin, an E 2 -regulated secretory protein, and led to apoptosis (►Fig. 1).
3
A predominant mediator of E 2 action in rodents is leukemia inhibitory factor (LIF), a member of the interleukin (IL)-6 cytokine family. Endometrial expression of LIF in mice is indispensable for implantation.
4,5 Upon its secretion, LIF binds to its specific receptor, LIFR, in the luminal epithelium, and through gp130, activates the januse kinase (JAK)-signal transducer and activator of transcription (STAT) JAK-STAT pathway that leads to acquisition of endometrial receptivity.
6
Using a model of endometrial epithelium specific, conditional Stat3 knockout, Pawar et al demonstrated that LIF-induced STAT3 activation triggers reorganization of the uterine epithelium by modulating different specific components of the junctional complex, such as E-cadherin, α and β-catenin, and claudins. 7 Moreover, epithelial STAT3 regulates proliferation and differentiation of stromal cells during decidualization.
This paracrine effect of the epithelium on the stroma is mediated by the epidermal growth factor (EGF)-like growth factors, Egf, Hbegf, and Areg, that are produced downstream to the LIF-STAT3 signaling. 7 Although LIF is a vital player in the mouse endometrium, its role in the human is still inconclusive. This cytokine reaches its peak level in human epithelium in the mid-secretory phase, the WOI, which is the receptive phase of the cycle. 8 Some clinical studies indicate that low levels of LIF as well as its receptor are associated with unexplained infertility and with endometriosis, 9-12 whereas other studies could not demonstrate such correlation.
13
Furthermore, it was reported that LIF administration to in vitro fertilization (IVF) patients did not improve pregnancy outcome.
14
The predominant hormone during the receptive phase of the human endometrial cycle is P 4 , secreted by the corpus luteum that stimulates endometrial cell differentiation following E 2 priming. In fact, P 4 regulation is crucial for the transition of the endometrium from its nonreceptive to its receptive phase. This hormone modulates the expression of implantation-associated genes in the endometrium and is a key regulator of the transformation of the stromal cells to decidual cells, known as decidualization.
15 Like E 2 , the activity of P 4 is exerted through its binding to two receptors, PRA and PRB, that function in a tissue-specific manner. The together, these studies suggest that the balance between uterine E 2 and P 4 activities is crucial for normal receptivity and that this balance is regulated by stromal-epithelial communication.
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Other Genes that Are Involved in the Development of a Receptive Endometrium
One of the genes that is up-regulated during the WOI is proprotein convertase 6 (PC6), localized mainly at the site of implantation. In vivo ablation of the PC6 in mouse endome- 
33
It has been suggested that normal implantation takes place in an inflammatory environment provided by the receptive endometrium.
34, 35 In this context, prostaglandins (PGs) were demonstrated to be crucial for successful embryo implantation. Uterine depletion of cytosolic phospholipase A 2 , cyclooxygenase-2 (COX-2), and lysophosphatidic acid receptor LPA 3 , which have a central role in PG synthesis, leads to implantation failure in the mouse. [36] [37] [38] In human, defective PG synthesis correlates with repeated implantation failure in patients undergoing IVF treatment. 39 It was suggested that the levels of PGE 2 and PGF 2α in the uterine fluid, 24 hours before embryo transfer, could predict pregnancy outcome. In vitro experiments demonstrated that embryo adhesion to the epithelium is significantly reduced in epithelial cells pretreated with inhibitors of PG synthesis.
39
Involvement of the Immune System in Acquisition of Endometrial Receptivity
In contrast to its classical role in protecting the organism from invading foreign antigens, the endometrial immune system supports invasion and maintenance of the fetal semiallograft. 40 This paradoxical immune activity is a result of specific E 2 and P 4 -regulated cytokines and chemokines which serve to recruit specific leukocyte populations into the endometrium and regulate their differentiation. Leukocytes in human endometrium comprise different subpopulations, including uterine natural killer (uNK) cells, macrophages (Mac), and dendritic cells (DCs). The uNK cells, the abundance of which increases at the WOI and early pregnancy, compose approximately 70% of the decidual leukocyte population, and their role in stromal decidualization has been suggested. 41 Circulating NK cells in the peripheral blood are cytotoxic, however, upon their infiltration into the endometrium, they undergo differentiation into uNK cells, losing their killing activity.
42
The cytokine IL-15, secreted by DCs and endometrial cells, as well as transforming growth factor beta (TGF-β)1, secreted by Mac, are essential for this process. 41, [43] [44] [45] Mac and DCs are the major antigen presenting cells in the endometrium. They are present in the endometrium throughout the menstrual cycle and demonstrate increased abundance during the WOI and early pregnancy.
46-48
Accumulating evidence suggests that, in addition to their classical role in mediating immune response, DCs and Mac have a pivotal role in implantation. Transient deletion of DCs resulted in a faulty decidualization characterized by reduced proliferation, differentiation, and delayed angiogenesis.
49,50
Supporting their role in implantation, therapy by DCs administration significantly decreases the rate of spontaneous resorption of embryos in the mouse uterus. 51 As initially reported by us, and later by others, endometrial biopsy substantially increases implantation and clinical pregnancy rates in IVF patients with repeated implantation failure.
52-58
This increase in pregnancy rate was associated with elevation of DCs and Mac abundance. 59 Endometrial Mac and DCs 
Implantation
Embryo implantation is divided into three sequential stages: apposition, adhesion, and invasion.
Apposition
Apposition is a dynamic process, during which the freefloating blastocyst and the receptive endometrium initially interact. Having tethering and rolling over, "scanning" the uterine surface, the embryo spots the specific site of implantation and attaches the endometrium. A similarity between the rolling blastocyst in the uterus and the leukocyte migration on the endothelial wall has been suggested. 73 In both processes, interaction is established by binding of the Lselectin molecule expressed on the leukocytes as well as on the trophoblast cells, to its oligosaccharide ligands, localized on the endothelial wall and on the luminal epithelium, respectively.
74 Surprisingly, L-selectin-deficient mice are fertile. 75 However, in human, elevated level of the L-selectin ligand, MECA-79, is associated with improved implantation, while decreased expression of sulfotransferase, GlcNAc6ST-2, which is involved in the generation of functional L-selectin ligands in the endometrial cells, was associated with infertility. 76, 77 It has been further shown that reduced expression of endometrial fucosyltransferase, FUT7, generating fucosylated L-selectin ligands, reduces the embryo-endometrium interaction, while overexpression of FUT7 has a positive effect on implantation in vitro and in vivo in the mouse. 78, 79 Attempts to localize the L-selectin ligand, MECA-79, in human endometrium detected a high abundance of this ligand on the pinopods, 80 emphasizing the importance of development of these organelles for the initial interaction of the human embryo with the receptive endometrium. Another protein that was suggested to mediate the initial embryo-endometrium interaction is heparin-binding EGF (HB-EGF)-like growth factor. 81 The highest expression of HB-EGF was found at the WOI in both human and mouse endometrium. In the mouse, HB-EGF is localized in the luminal epithelium surrounding the blastocysts. 82 In human, it is expressed at the WOI in the epithelium and stroma.
83,84
In the luminal epithelium, its localization was associated with the fully developed pinopodes. 85 The receptors for HB-EGF (ErbBs) are expressed on the blastocyst surface. 86 Deletion of HB-EGF from the uterus in the mouse resulted in a reduced litter size. 87 Further evidence for the HB-EGF-ErbB4-mediated attachment of the human blastocyst was generated using in vitro experimental models. 88 It was also suggested that HB-EGF promotes blastocyst growth, zona-hatching, and trophoblast outgrowth followed by its differentiation to its adhesive state. 82, 89 As previously reported, cytokines/chemokines secreted by the endometrial cells as well as by the infiltrated immune cells are essential for endometrial receptivity and implantation. Chemokines, secreted by the endometrial cells during the WOI, create a gradient that attracts the blastocyst to the implantation site. 90 In vitro experiments indeed demonstrated that IL-6, MIP-1B, CX3CL1, and IP-10 are effective chemoattractants of the human trophoblast cells. [91] [92] [93] Furthermore, a positive correlation between endometrial levels of MIP-1B and IP-10 and successful implantation in IVF patients was demonstrated by us and by others. 59, 94 The role of IP-10 in regulation of blastocyst migration, apposition, and initial adhesion has been confirmed in vivo in the mouse as well. 95 Attachment of the blastocyst at the precise implantation site is ensured by mucins (MUC), O-glycosylated proteins that cover the luminal epithelium surface thus preventing an undesirable embryo-uterine interaction at the incorrect site. One of the most studied mucins in the endometrium is MUC1. Its removal is necessary for successful implantation in many species. 96 In humans, expression of endometrial MUC1 is increased during the receptive phase under the regulation of P 4 and different proinflammatory cytokines. that human endometrial epithelial cells induce the secretion of the cytokines IL-1α and IL-1β by the blastocyst, and these in turn, increase ITG expression by the epithelial cells. A bidirectional crosstalk between the blastocyst and the endometrium is also suggested by a recent demonstration that factors released to the medium by human blastocysts that successfully implanted following embryo transfer, alter messenger RNA levels of several genes in the epithelial cells, in vitro, facilitating their adhesive properties.
121
Invasion
Invasion is the final step of implantation, during which the trophoblast fractures the epithelial lining of the uterus and penetrates into the endometrial stroma. Decidualized stromal cell and uNK cells secrete factors that stimulate trophoblast invasion by altering expression of key regulators such as, ITGs, MMPs, and their tissue inhibitors of metalloproteases (TIMPS). 41, [122] [123] [124] They also induce vascular growth and remodeling by secretion of large amount of angiogenic factors, MMP-2 and MMP-9. 92, 125 Moreover, uNK cells secrete factors that trigger endometrial stromal cells to produce cytokines/chemokines, such as IL-15, which in turn supports uNK differentiation, while others, IL-8, CCL8, and CXCL1, act synergistically with uNK-secreted chemokines to induce trophoblast migration.
126
Regulation of endometrial remodeling and clearance of apoptotic trophoblast cells during trophoblast invasion is attributed to Mac. 127, 128 The invading trophoblast secretes chemokines, such as CXCL16 and CXCL12 that recruit and activate immune cells to the deciduas. [129] [130] [131] Monocytes that are recruited and "educated" by the trophoblasts cells, positively affect trophoblast development and function, by both secretion of cytokines such as IL-6, IL-8, MCP-1, and GROα and stimulating trophoblast to secrete cytokines that in an autocrine manner facilitate their own growth, survival, and invasion.
130
Proteases pave the way for the invading trophoblast by digesting the extracellular matrix. The human MMP gene family includes 23 members, 132 of which MMP-2 and -9 were mostly studied. Almost all MMPs are produced by the trophoblast, decidual stromal cells, and uNK cells, 133 and their expression is tightly regulated by hormones, cytokines, and growth factors as well as by the TIMPs. It was demonstrated that EGF and cytokines, such as IL-6, IL-1β, TNFα, and IL-8, stimulate trophoblast invasion by increasing levels of trophoblast MMP-2 and -9. [134] [135] [136] [137] [138] Activation of STAT3 by LIF was shown to regulate trophoblast invasiveness by TIMP-1 downregulation. 124 However, TGF-α1 inhibits the proteolytic activity of cytotrophoblast cells by up-regulating TIMP-1 and 2. 138, 139 Another negative regulator of MMP activity in the trophoblast cells is P 4 that inhibits the expression of MMP-2, MMP-3, MMP-7, and MMP-9 and increases the expression of TIMP-3, thus restraining trophoblast invasion. 15 In addition to MMPs, the invasive trophoblast expresses various members of a disintegrin and MMPs (ADAMs), such as ADAM8, -12, -19, and -28. 140 In contrast to the secreted forms of MMPs, most of the ADAM family members are membrane proteins. It was suggested that ADAM family members regulate trophoblast invasion by proteolytic shedding of the membrane anchoring ectodomains, thus activating variety of chemokines, cytokines, growth factors, receptors, and their ligands.
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Epilogue
Although protocols for infertility treatments are being constantly improved, implantation remains the rate-limiting step for their success. In IVF patients, who generate highquality embryos but fail to conceive, it is apparently inadequate uterine receptivity that is responsible for implantation failure. Many efforts have been invested in identifying endometrial biomarkers that can predict implantation competence. The studies discussed in this review suggest different implantation-associated genes/proteins as promising candidates. Using the "omics" approach (transcriptomics, proteomics, and secretomics) in endometrial biopsies/uterine aspiration, groups of genes/proteins that characterize a receptive endometrium were proposed. 142 A new assay defined as endometrial receptivity array (see article "Endometrium and Implantation Clinical Management of Endometrial Receptivity" by Blesa and Ruiz-Alonso in this issue) seems to provide accurate and consistent parameters for the evaluation of uterine receptivity. [143] [144] [145] [146] Evaluating uterine receptivity using the appropriate biomarkers could provide a potential tool for assessing the success of infertility 
